Scientists Target Senescent 'Zombie Cells' to Slow Aging
Senescent cells, often called zombie cells, accumulate with age and release inflammatory chemicals instead of dying. The immune system's ability to clear these cells declines over time, contributing to age-related disease. Some researchers are exploring treatments that either kill senescent cells directly or rejuvenate immune cells so they can remove them more effectively.
Senescent cells are damaged cells that stop dividing but do not die. They can persist in tissues for years, releasing inflammatory substances. Normally, macrophages recognize surface signals on dying cells and remove them, but this cleanup weakens with age.
Senescence can aid wound repair, yet its buildup is tied to inflammation, poorer organ function, heart disease and dementia. In mice, senolytic drugs push these cells into programmed death, lowering inflammation and improving tissue function. Researchers also ask whether restoring immune-cell function might clear them.
If these approaches translate, older adults and people at risk of age-related conditions could benefit, potentially extending healthspan and reducing disease burden. Families, caregivers, and health systems may see changed demand for long-term care, though access, cost, and safety remain uncertain. Because most evidence comes from mice and early research, societal effects may take years and depend on clinical results.